Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001628280-18-003647
Filing Date
2018-03-28
Accepted
2018-03-28 11:17:16
Documents
3
Period of Report
2018-03-28

Document Format Files

Seq Description Document Type Size
1 6-K/A q4-2017x6k.htm 6-K/A 22893
2 EXHIBIT 99.2 q4-2017xex992fsxannual.htm EX-99.2 1750939
3 pwca01.jpg GRAPHIC 7895
  Complete submission text file 0001628280-18-003647.txt   1785954
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-38064 | Film No.: 18717420
SIC: 2834 Pharmaceutical Preparations